RAND Europe Researcher Participates in AIDS 2012 Conference
As a key researcher in the Mapping Pathways project, RAND Europe senior analyst Molly Morgan Jones was at the AIDS 2012 conference in Washington, D.C., 22-27 July.
Morgan Jones participated in a satellite session on Sunday, entitled "From Revolution to Reality: How Will New Science Impact the U.S. National HIV/AIDS Strategy?"
The official overview describes this session as follows:
- The U.S. National HIV/AIDS Strategy (NHAS) has been in place for two years. Since its release, scientific breakthroughs and new research have transformed our thinking about the U.S. HIV epidemic. HPTN 052 and successful PrEP and microbicide trials demonstrate that biomedical interventions hold promise that was unthinkable just two years ago. At the same time, Gardner and his co-authors shine the spotlight on the human factors impacting the epidemic – half of people with HIV are not in medical care, and just one in four achieves treatment success. Key researchers, including some who contributed to these breakthrough findings, will weigh in on the implications of new research on the U.S. Strategy.
Morgan Jones's talk was entitled, "Mapping Pathways: Exploring strategies in the use of ARV-based prevention."
Other ways in which Mapping Pathways participated in the conference include:
- Poster presentations on Monday, 23 July, 12:30pm – 2:30pm: "Mapping Pathways: Developing the evidence base for biomedical prevention strategies" [MOPE591] and "Synthesising the empirical evidence for ARV-based prevention strategies to map pathways to sound HIV prevention planning" [M0PE590]
- Satellite session on Tuesday, 24 July, 6:30pm – 8:30pm in Mini Room 2: “Microbicides: The Road Ahead”
- Presentation/Discussion on Wednesday, 25 July, 10:30am – Noon in the MSM Networking Zone, Global Village: “Is it Celebration Time? What needs to happen for gay men/MSM to make the most of ARV-based prevention (PrEP, rectal microbicides and treatment as prevention) around the world.”